Jubilant Pharmova Limited (JUBLPHARMA.BO)
INR 881.1
(-0.37%)
INR 881.1
(-0.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 19.64 Billion INR | -50.85% |
| 2022 | 39.96 Billion INR | -6.45% |
| 2021 | 42.72 Billion INR | 1.47% |
| 2020 | 42.1 Billion INR | 0.38% |
| 2019 | 41.94 Billion INR | -18.96% |
| 2018 | 51.75 Billion INR | 20.9% |
| 2017 | 42.81 Billion INR | 21.87% |
| 2016 | 35.13 Billion INR | 7.24% |
| 2015 | 32.76 Billion INR | 14.64% |
| 2014 | 28.57 Billion INR | -5.83% |
| 2013 | 30.34 Billion INR | 7.07% |
| 2012 | 28.34 Billion INR | 7.25% |
| 2011 | 26.42 Billion INR | 65.12% |
| 2010 | 16 Billion INR | -30.39% |
| 2009 | 22.98 Billion INR | 493.77% |
| 2008 | 3.87 Billion INR | -70.66% |
| 2007 | 13.19 Billion INR | 56.96% |
| 2006 | 8.4 Billion INR | 27.07% |
| 2005 | 6.61 Billion INR | 218.64% |
| 2004 | 2.07 Billion INR | -50.71% |
| 2003 | 4.21 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 11.87 Billion INR | 2.93% |
| 2024 Q1 | 5.26 Billion INR | -8.48% |
| 2023 FY | 19.64 Billion INR | -50.85% |
| 2023 Q4 | 5.75 Billion INR | -49.07% |
| 2023 Q2 | 11.09 Billion INR | 6.02% |
| 2023 Q1 | 10.46 Billion INR | 33.09% |
| 2023 Q3 | 11.29 Billion INR | 1.79% |
| 2022 Q3 | 10.55 Billion INR | -4.22% |
| 2022 Q4 | 7.86 Billion INR | -25.48% |
| 2022 FY | 39.96 Billion INR | -6.45% |
| 2022 Q1 | 10.53 Billion INR | 31.57% |
| 2022 Q2 | 11.01 Billion INR | 4.57% |
| 2021 Q1 | 12.52 Billion INR | 32.55% |
| 2021 FY | 42.72 Billion INR | 1.47% |
| 2021 Q2 | 11.94 Billion INR | -4.66% |
| 2021 Q3 | 10.24 Billion INR | -14.25% |
| 2021 Q4 | 8 Billion INR | -21.82% |
| 2020 Q2 | 11.02 Billion INR | 25.67% |
| 2020 Q1 | 8.77 Billion INR | -24.0% |
| 2020 Q3 | 12.85 Billion INR | 16.56% |
| 2020 Q4 | 9.45 Billion INR | -26.46% |
| 2020 FY | 42.1 Billion INR | 0.38% |
| 2019 Q4 | 11.54 Billion INR | 1.51% |
| 2019 Q2 | 14.63 Billion INR | 4.7% |
| 2019 Q1 | 13.97 Billion INR | 29.4% |
| 2019 Q3 | 11.37 Billion INR | -22.28% |
| 2019 FY | 41.94 Billion INR | -18.96% |
| 2018 Q4 | 10.8 Billion INR | -26.89% |
| 2018 Q3 | 14.77 Billion INR | 7.95% |
| 2018 Q2 | 13.68 Billion INR | 9.47% |
| 2018 FY | 51.75 Billion INR | 20.9% |
| 2018 Q1 | 12.5 Billion INR | -6.22% |
| 2017 Q4 | 13.32 Billion INR | 6.24% |
| 2017 Q3 | 12.54 Billion INR | 23.79% |
| 2017 Q2 | 10.13 Billion INR | 6.15% |
| 2017 FY | 42.81 Billion INR | 21.87% |
| 2017 Q1 | 9.54 Billion INR | -2.1% |
| 2016 Q2 | 9.3 Billion INR | -2.64% |
| 2016 Q1 | 9.55 Billion INR | 4.26% |
| 2016 FY | 35.13 Billion INR | 7.24% |
| 2016 Q3 | 9.68 Billion INR | 4.13% |
| 2016 Q4 | 9.75 Billion INR | 0.69% |
| 2015 FY | 32.76 Billion INR | 14.64% |
| 2015 Q4 | 9.16 Billion INR | 8.75% |
| 2015 Q3 | 8.42 Billion INR | -6.72% |
| 2015 Q2 | 9.03 Billion INR | 1.67% |
| 2015 Q1 | 8.88 Billion INR | 60.73% |
| 2014 Q4 | 5.52 Billion INR | -31.56% |
| 2014 FY | 28.57 Billion INR | -5.83% |
| 2014 Q1 | 7.41 Billion INR | 21.17% |
| 2014 Q2 | 7.55 Billion INR | 1.96% |
| 2014 Q3 | 8.07 Billion INR | 6.86% |
| 2013 Q4 | 6.11 Billion INR | -26.5% |
| 2013 FY | 30.34 Billion INR | 7.07% |
| 2013 Q2 | 8.54 Billion INR | 15.99% |
| 2013 Q1 | 7.36 Billion INR | -7.94% |
| 2013 Q3 | 8.32 Billion INR | -2.54% |
| 2012 Q1 | - INR | -100.0% |
| 2012 Q3 | 7.6 Billion INR | 0.92% |
| 2012 FY | 28.34 Billion INR | 7.25% |
| 2012 Q2 | 7.53 Billion INR | 0.0% |
| 2012 Q4 | 7.99 Billion INR | 5.19% |
| 2011 Q4 | 1.41 Billion INR | -79.57% |
| 2011 Q3 | 6.91 Billion INR | 0.0% |
| 2011 FY | 26.42 Billion INR | 65.12% |
| 2010 FY | 16 Billion INR | -30.39% |
| 2009 FY | 22.98 Billion INR | 493.77% |
| 2008 FY | 3.87 Billion INR | -70.66% |
| 2007 FY | 13.19 Billion INR | 56.96% |
| 2006 FY | 8.4 Billion INR | 27.07% |
| 2005 FY | 6.61 Billion INR | 218.64% |
| 2004 FY | 2.07 Billion INR | -50.71% |
| 2003 FY | 4.21 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 26.652% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 87.301% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -57.991% |
| Granules India Limited | 16.79 Billion INR | -16.928% |
| Indoco Remedies Limited | 6.04 Billion INR | -225.144% |
| Achyut Healthcare Limited | 4.86 Million INR | -403993.808% |
| Ajanta Pharma Limited | 21.06 Billion INR | 6.746% |
| Alkem Laboratories Limited | 52.29 Billion INR | 62.439% |
| Alpa Laboratories Limited | 188.89 Million INR | -10298.899% |
| Brooks Laboratories Limited | 65.62 Million INR | -29834.471% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -215.667% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -1234.619% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -431.548% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 87.994% |
| Eris Lifesciences Limited | 10.42 Billion INR | -88.39% |
| FDC Limited | 8.33 Billion INR | -135.676% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 71.672% |
| Gufic Biosciences Limited | 4.16 Billion INR | -371.315% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | -217.111% |
| Ipca Laboratories Limited | 29.8 Billion INR | 34.106% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -2910.006% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -10092.137% |
| Lasa Supergenerics Limited | 121.02 Million INR | -16129.86% |
| Laurus Labs Limited | 24.62 Billion INR | 20.216% |
| Lupin Limited | 123.71 Billion INR | 84.123% |
| Mankind Pharma Limited | 44.52 Billion INR | 55.879% |
| Medicamen Biotech Limited | 495.49 Million INR | -3864.319% |
| Medico Remedies Limited | 262.14 Million INR | -7393.21% |
| Megasoft Limited | 342.07 Million INR | -5642.375% |
| NATCO Pharma Limited | 25.73 Billion INR | 23.675% |
| Piramal Pharma Limited | 24.47 Billion INR | 19.729% |
| RPG Life Sciences Limited | 2.48 Billion INR | -691.099% |
| Sigachi Industries Limited | 2 Billion INR | -881.03% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 92.401% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -376.393% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -1984.361% |
| Unichem Laboratories Limited | 4.86 Billion INR | -303.767% |
| Wanbury Limited | 1.73 Billion INR | -1035.012% |
| Windlas Biotech Limited | 1.33 Billion INR | -1367.209% |
| ZIM Laboratories Limited | 1.26 Billion INR | -1450.493% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 84.312% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 3360.758% |
| Divi's Laboratories Limited | 32.44 Billion INR | 39.448% |
| Hester Biosciences Limited | 1.27 Billion INR | -1442.26% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -239.762% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -1161.972% |
| Bal Pharma Limited | 770.19 Million INR | -2450.393% |
| Strides Pharma Science Limited | 14.38 Billion INR | -36.522% |
| Venus Remedies Limited | 2.18 Billion INR | -799.988% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -236.852% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -560.922% |
| Shilpa Medicare Limited | 3.54 Billion INR | -453.814% |
| Aarti Drugs Limited | 8.31 Billion INR | -136.202% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -328.812% |
| Suven Life Sciences Limited | -200.79 Million INR | 9882.517% |
| Ind-Swift Limited | 2.17 Billion INR | -804.153% |
| Valiant Laboratories Limited | -60.66 Million INR | 32479.995% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 13.467% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -2180.887% |
| Themis Medicare Limited | 1.5 Billion INR | -1206.134% |
| Hikal Limited | 3.14 Billion INR | -524.96% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 57.989% |
| Sequent Scientific Limited | 2.97 Billion INR | -559.442% |
| Novartis India Limited | 1.32 Billion INR | -1380.368% |
| Wockhardt Limited | 16.24 Billion INR | -20.954% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -134628.424% |
| Neuland Laboratories Limited | 8.24 Billion INR | -138.159% |
| Morepen Laboratories Limited | 6.16 Billion INR | -218.814% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -3065.79% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -2691.765% |